A Modern Approach to Dyslipidemia.
Berberich AJ, Hegele RA.
Endocr Rev. 2022 Jul 13;43(4):611-653. doi: 10.1210/endrev/bnab037.
2024 KSoLA consensus on secondary dyslipidemia.
Won H, Bae JH, Lim H, Kang M, Kim M, Lee SH; Clinical Practice Guidelines Committee, Korean Society of Lipid and Atherosclerosis (KSoLA).
Korean J Intern Med. 2024 Sep;39(5):717-730. doi: 10.3904/kjim.2024.156. Epub 2024 Aug 30.
Obesity and Dyslipidemia.
Nussbaumerova B, Rosolova H.
Curr Atheroscler Rep. 2023 Dec;25(12):947-955. doi: 10.1007/s11883-023-01167-2. Epub 2023 Nov 18.
Dyslipidemia Secondary to the Use of HAART in Adults: A Systematic Review.
Oliveira DPR, Macêdo APA, Dos Santos Gonçalves M, Couto RD.
Curr Drug Res Rev. 2022;14(3):239-246. doi: 10.2174/2589977514666220519165549.
Non-HDL-cholesterol in dyslipidemia: Review of the state-of-the-art literature and outlook.
Raja V, Aguiar C, Alsayed N, Chibber YS, ElBadawi H, Ezhov M, Hermans MP, Pandey RC, Ray KK, Tokgözoglu L, Zambon A, Berrou JP, Farnier M.
Atherosclerosis. 2023 Oct;383:117312. doi: 10.1016/j.atherosclerosis.2023.117312. Epub 2023 Sep 30.
Medical Management of Dyslipidemia for Secondary Stroke Prevention: Narrative Review.
Chang Y, Eom S, Kim M, Song TJ.
Medicina (Kaunas). 2023 Apr 17;59(4):776. doi: 10.3390/medicina59040776.
Secondary Dyslipidemia In Obese Children - Is There Evidence For Pharmacological Treatment?
Radaelli G, Sausen G, Cesa CC, Portal VL, Pellanda LC.
Arq Bras Cardiol. 2018 Sep;111(3):356-361. doi: 10.5935/abc.20180155. Epub 2018 Aug 23.
Nutrition interventions for adults with dyslipidemia: A Clinical Perspective from the National Lipid Association.
Kirkpatrick CF, Sikand G, Petersen KS, Anderson CAM, Aspry KE, Bolick JP, Kris-Etherton PM, Maki KC.
J Clin Lipidol. 2023 Jul-Aug;17(4):428-451. doi: 10.1016/j.jacl.2023.05.099. Epub 2023 Jun 2.
Global epidemiology of dyslipidaemias.
Pirillo A, Casula M, Olmastroni E, Norata GD, Catapano AL.
Nat Rev Cardiol. 2021 Oct;18(10):689-700. doi: 10.1038/s41569-021-00541-4. Epub 2021 Apr 8.
[Secondary Dyslipidemia-Diagnosis of Drug-Induced Dyslipidemia-].
Hirayama S.
Rinsho Byori. 2016 May;64(5):533-538.
